Dr. Song’s research is focused on developing safer and more efficient AAV vectors for liver-target gene therapy. He is working on the evaluation of hepatotoxicity risks in 3D spheroids models for AAV gene therapy.

Animal Models, DNA Sequencing, High Content Imaging/Screening, Omics (Metabolomics, Proteomics, Lipidomics), Primary Cell Culture, Adverse Drug Reactions, Clinical Education, Comparative Effectiveness, Medication Optimization, Metabolism, Pain, Pharmacoeconomics, Pharmacogenetics, Pharmacogenomics, Precision Dosing, Precision Health, Precision Medicine

Assay Development, Chemical Libraries, High Content Imaging/Screening, High Throughput Screening, Phage Display, Surface Plasmon Resonance, Biophysics, Cancer, Chemical Biology, Chemical Probes, Drug Discovery, Epigenetics, High Throughput Screens, Protein Expression, Protein Kinase Inhibitors, Protein engineering, Structure Activity Relationship

Chemogenetics, Directed Evolution, High Content Imaging/Screening, High Throughput Screening, X-ray Crystallography, Biased Agonism, Drug Discovery, Drug Safety, G Protein-coupled Receptors, Mental Health, Neuropharmacology, Neuroscience, Opioids, Pharmacology, Protein Chemistry, Protein Expression, Protein engineering, Structural Biology, Structure Activity Relationship, Structure-based Drug Dosing